In adults with atherosclerosis or diabetes and LDL cholesterol ≥90 mg/dL but no prior heart attack or stroke, evolocumab reduces the incidence of cardiovascular events in a population with a median age of 66 years, 43% women, and 93% White, and this effect is not necessarily generalizable to younger or racially diverse populations.

Source: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports

74score

Challenges

0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect

1 study reviewed

In plain English

Evolocumab lowers the risk of cardiovascular events in middle-aged and older adults with atherosclerosis or diabetes and high LDL cholesterol, but this benefit has only been observed in a population that is mostly White and not in younger or more racially diverse groups.

See the scientific wording

In adults with atherosclerosis or diabetes and LDL cholesterol ≥90 mg/dL but no prior heart attack or stroke, evolocumab’s benefit on cardiovascular events is observed in a population with a median age of 66 years, 43% women, and 93% White, suggesting the effect is generalizable to middle-aged and older adults with these conditions but not necessarily to younger or racially diverse populations.

Why this might work

A drug blocks a protein that normally destroys receptors on the liver that remove bad cholesterol from the blood. With more receptors available, the liver pulls more bad cholesterol out of the bloodstream. Lower cholesterol levels slow the buildup of fatty plaques in arteries, which reduces the chance of heart attacks and strokes.

Verified mechanismbased on 1 study

What the research says

1 study

Study: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
This study showed that evolocumab helped older, mostly white adults with high cholesterol and artery disease avoid heart attacks and strokes — but it didn’t include enough young people or people of other races to know if it works the same for them.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.